Browse: Companies | People | Financial Organizations
Home > Companies > Selecta Biosciences

General Information

Websiteselectabio.com
CategoryBioTech
Employees
Descriptionnanoparticle immunomodulatory drugs

Offices

Funding

Tags

Selecta Biosciences

Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Our proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles.

Milestones

  • Received $15.1M in Series B funding. (2/25/09)
    Posted 4/14/09 at 10:01am

Videos

Screenshots

Sources

  1. Selecta Biosciences, Inc. Closes $15.1M Series B Financing (selectabio.com) [edit]
Edit This Page
Last Edited 7/2/09

Revision History RSS Picture

Recent Incoming Links

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy